GnT-V Antibodies

Santa Cruz Biotechnology offers a broad range of GnT-V monoclonal antibodies for advanced research in glycosylation processes. GnT-V monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GnT-V, or N-acetylglucosaminyltransferase V, plays a significant role in the biosynthesis of complex N-glycans, influencing cell signaling, adhesion, and immune responses. GnT-V activity is particularly relevant in cancer biology, as altered glycosylation patterns can affect tumor progression and metastasis. Research focused on GnT-V can reveal potential therapeutic targets and biomarkers. Scientists worldwide use GnT-V monoclonal antibodies to advance their understanding of glycosylation mechanisms. Ongoing studies of GnT-V continue to uncover new aspects of cellular regulation and disease development. Research utilizing GnT-V monoclonal antibodies contributes to expanding knowledge in glycobiology and related fields. Santa Cruz Biotechnology monoclonal antibodies support researchers in making meaningful discoveries that advance scientific understanding of cellular processes and disease mechanisms.